Gevilon en es it fr

Gevilon Brand names, Gevilon Analogs

Gevilon Brand Names Mixture

  • No information avaliable

Gevilon Chemical_Formula


Gevilon RX_link

Gevilon fda sheet

Gevilon FDA

Gevilon msds (material safety sheet)

Gevilon Synthesis Reference

P. L. CREGER, U.S. Pat. 3,674,836 (1972)

Gevilon Molecular Weight

250.333 g/mol

Gevilon Melting Point

61-63 oC

Gevilon H2O Solubility

10 mg/mL (in base)

Gevilon State


Gevilon LogP


Gevilon Dosage Forms

Tablets; Capsules

Gevilon Indication

For treatment of adult patients with very high elevations of serum triglyceride levels (types IV and V hyperlipidemia) who are at risk of developing pancreatitis (inflammation of the pancreas) and who do not respond adequately to a strict diet.

Gevilon Pharmacology

Gemfibrozil, a fibric acid antilipemic agent similar to clofibrate, is used to treat hyperlipoproteinemia and as a second-line therapy for type IIb hypercholesterolemia. It acts to reduce triglyceride levels, reduce VLDL levels, reduce LDL levels (moderately), and increase HDL levels (moderately).

Gevilon Absorption

Well absorbed from gastrointestinal tract (within 1-2 hours).

Gevilon side effects and Toxicity

Oral, mouse: LD50 = 3162 mg/kg. Symptoms of overdose include abdominal cramps, diarrhea, joint and muscle pain, nausea, and vomiting.

Gevilon Patient Information

Gemfibrozil is used to lower high triglyceride and cholesterol levels. Notify your physician if you are pregnant or nursing. Gemfibrozil should be taken 30 minutes before the morning and evening meals. This medication may cause dizziness or blurred vision; use caution while driving or operating hazardous machinery. Gemfibrozil may cause an increase in blood sugar. If you have diabetes mellitus, carefully monitor blood sugar levels. Notify your physician if you develop severe stomach pain, muscle pain or weakness, or unexplained fever.

Gevilon Organisms Affected

Humans and other mammals